Display options
Share it on

Case Rep Womens Health. 2020 Mar 30;26:e00197. doi: 10.1016/j.crwh.2020.e00197. eCollection 2020 Apr.

Alleviation of notalgia paresthetica with duloxetine after several lines offailed treatment: A case report.

Case reports in women's health

Amnon A Berger, Ivan Urits, Jamal Hasoon, Thomas Simopoulos

Affiliations

  1. Department of Anesthesia, Critical Case and Pain Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States of America.

PMID: 32274333 PMCID: PMC7132164 DOI: 10.1016/j.crwh.2020.e00197

Abstract

Chronic pruritus affects up to 20% of the population; about 8% of patients suffer from neurogenic pruritus, including notalgia paresthetica (NP). This is a syndrome of benign, chronic itch of the unilateral medial border of the scapula of unknown etiology and limited treatment efficacy. Here we report the background on NP, followed by a classic case presentation of a 63-year-old woman. We report on difficulty in her diagnosis and numerous failed lines of treatment, until initiation of treatment with duloxetine, which provided her with long-lasting benefit for the first time. Delay in diagnosis is common for NP, and though there are many options for treatment, evidence is lacking to support their efficacy. Finding an effective, well-tolerated regimen to alleviate long-term suffering brought on by this syndrome is heavily dependent on early identification. Our case provides anecdotal evidence for both treatment efficacy as well as the etiology of this poorly understood phenomenon.

© 2020 Published by Elsevier B.V.

Keywords: Duloxetine; Neurogenic itch; Notalgia Paresthetica; Pruritus

References

  1. J Am Acad Dermatol. 2014 Jun;70(6):1139-41 - PubMed
  2. Acta Clin Croat. 2018 Dec;57(4):721-725 - PubMed
  3. Actas Dermosifiliogr. 2014 Jan-Feb;105(1):74-7 - PubMed
  4. J Dermatol. 2007 May;34(5):315-9 - PubMed
  5. J Am Acad Dermatol. 2001 Oct;45(4):630-2 - PubMed
  6. J Am Acad Dermatol. 2005 Jun;52(6):1085-7 - PubMed
  7. J Dermatolog Treat. 2019 Apr 3;:1-9 - PubMed

Publication Types